Contaminated glutathione injections: what the endotoxin recalls show

Key takeaways

• The CDC, FDA and state and local health departments are investigating illnesses in people who received glutathione injections, likely caused by bacterial endotoxin ³.
• The FDA says "dietary supplement grade" glutathione is "not an appropriate ingredient to make injectable drugs" ².
• At least three Texas pharmacies have recalled compounded glutathione injectables ³.
• No glutathione drug is FDA-approved in the US, and none is approved anywhere for skin lightening.

This is background rather than breaking news: the recalls began in August and the CDC's latest page we found is dated mid-September. But it is the clearest recent example of what can go wrong when an ingredient made for one purpose ends up in a vial for another. Glutathione is usually discussed as a wellness peptide, so the safety story gets less attention than the skin-lightening claims.

Where the glutathione story stands

Glutathione is a three-amino-acid peptide every cell makes on its own. On our site it sits at evidence level 3, with small human trials showing modest and inconsistent skin lightening. There is no FDA-approved glutathione drug; oral forms are sold as supplements, and injectables come from compounding pharmacies.

On August 5, 2026, Victory Medical Center Pharmacy in Austin, Texas, announced a voluntary nationwide recall of three lots of compounded glutathione 200 mg/mL multi-dose vials after its own testing found elevated bacterial endotoxin ¹. The lots had been distributed in Texas, Florida and New York. The company reported adverse events including fever, chills, severe headache, nausea, vomiting and a fast heart rate ¹.

What the FDA and CDC found

On August 27, the FDA said it had reports of at least 30 patients with adverse events after intravenous glutathione ². Several pharmacies had compounded from the same lot of ingredient, supplied by Medisca and labeled dietary supplement grade. Medisca told the FDA on August 20 that it had warned U.S. customers not to use it for injectables ².

The CDC's page, dated September 15, described more than 25 people sick in at least four states. At least three were hospitalized after IV glutathione, and one needed intensive care ³. The agency said the illnesses are likely linked to elevated endotoxin, and that supplement-labeled glutathione should not be used in sterile injectable drugs ³. The FDA says its investigation is ongoing ².

Why endotoxin is a different kind of problem

Endotoxins are substances produced by certain bacteria ³. The FDA says exposure can cause muscle pain, headache, nausea, vomiting, low blood pressure and death, though not all of these have been linked to the glutathione reports ². Supplement-grade ingredients may carry impurities and contaminants that are harmful when injected ².

This is not new. The FDA raised concerns about supplement-grade glutathione in sterile injectables in 2019 ², and the CDC cites an earlier outbreak in Australia in 2015 ³. The FDA's message to compounders is that they are responsible for confirming every component is suitable for its intended use, and that quality has to be built into each step rather than relying on testing alone ².

A separate enforcement thread: pharmacy quality systems

A Maven Regulatory Solutions summary says the FDA sent a warning letter dated September 18, 2026, to Empower Pharmacy in Houston after an inspection in November 2025 ⁴. The cited products were compounded versions of two GLP-1 weight-loss drugs, which the FDA described as "essentially copies of commercially available drug products" ⁴. The letter also flagged sterility-assurance problems, including inadequate airflow smoke studies and media-fill documentation questions ⁴.

It is a different product and a different issue, but the theme overlaps. Both stories are about documented controls in sterile compounding.

Quick hits on the label and the sport rules

Our glutathione entry notes that it is not prohibited by WADA, but an IV infusion above 100 mL per 12 hours is banned outside hospital or clinical settings.

Endotoxin is also a line item on a certificate of analysis. If you want to see how that line is reported, our guide on reading a peptide certificate of analysis walks through it. A lab report on one lot is not the same as proof of sterile manufacturing controls, which is what the FDA is policing.

The bottom line

The glutathione recalls show that "peptide" can describe a harmless molecule and a hazardous product at the same time. The problem, according to the FDA and CDC, was an ingredient grade unsuited to injection and elevated endotoxin, not glutathione itself. If someone has had symptoms after an injection or infusion, the CDC advises contacting a provider and seeking emergency care for severe symptoms ³.

This is educational information, not medical advice.

Sources

1. Victory Medical Center Pharmacy issues voluntary nationwide recall of certain lots of compounded glutathione — U.S. FDA, August 5, 2026. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/victory-medical-center-pharmacy-issues-voluntary-nationwide-recall-certain-lots-compounded
2. FDA reminds compounders not to use dietary supplement grade glutathione in injectables — U.S. FDA, August 27, 2026. https://www.fda.gov/drugs/human-drug-compounding/fda-reminds-compounders-not-use-dietary-supplement-grade-glutathione-injectables
3. Current situation: illnesses linked to glutathione injections — CDC, updated September 15, 2026. https://www.cdc.gov/healthcare-associated-infections/current-situation/index.html
4. FDA Empower Pharmacy warning letter, GLP-1 and CGMP compliance — Maven Regulatory Solutions, September 30, 2026. https://www.mavenrs.com/fda-empower-pharmacy-warning-letter-glp1-cgmp-compliance-2026